[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biosimilar Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

May 2023 | 116 pages | ID: GA3DCE661044EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

A biosimilar is a biological product that is very similar to a reference biologic and for which there are no clinically meaningful differences in terms of safety, purity, and potency.

The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Biosimilar market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Biosimilar market are covered in Chapter 9:
Novartis
Pfizer
Celltrion
BioXpress Therapeutics
Boehringer Ingelheim
Genor BioPharma
Allergan plc
Intas Pharmaceuticals Limited
Reliance Life Sciences
BIOCAD
Dr. Reddy’s Laboratories
Coherus BioSciences
Biocon

In Chapter 5 and Chapter 7.3, based on types, the Biosimilar market from 2017 to 2027 is primarily split into:
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin

In Chapter 6 and Chapter 7.4, based on applications, the Biosimilar market from 2017 to 2027 covers:
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa

Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Biosimilar market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Biosimilar Industry.

2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.

3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilar Market
1.2 Biosimilar Market Segment by Type
  1.2.1 Global Biosimilar Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Biosimilar Market Segment by Application
  1.3.1 Biosimilar Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Biosimilar Market, Region Wise (2017-2027)
  1.4.1 Global Biosimilar Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Biosimilar Market Status and Prospect (2017-2027)
  1.4.3 Europe Biosimilar Market Status and Prospect (2017-2027)
  1.4.4 China Biosimilar Market Status and Prospect (2017-2027)
  1.4.5 Japan Biosimilar Market Status and Prospect (2017-2027)
  1.4.6 India Biosimilar Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Biosimilar Market Status and Prospect (2017-2027)
  1.4.8 Latin America Biosimilar Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Biosimilar Market Status and Prospect (2017-2027)
1.5 Global Market Size of Biosimilar (2017-2027)
  1.5.1 Global Biosimilar Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Biosimilar Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Biosimilar Market

2 INDUSTRY OUTLOOK

2.1 Biosimilar Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Biosimilar Market Drivers Analysis
2.4 Biosimilar Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Biosimilar Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Biosimilar Industry Development

3 GLOBAL BIOSIMILAR MARKET LANDSCAPE BY PLAYER

3.1 Global Biosimilar Sales Volume and Share by Player (2017-2022)
3.2 Global Biosimilar Revenue and Market Share by Player (2017-2022)
3.3 Global Biosimilar Average Price by Player (2017-2022)
3.4 Global Biosimilar Gross Margin by Player (2017-2022)
3.5 Biosimilar Market Competitive Situation and Trends
  3.5.1 Biosimilar Market Concentration Rate
  3.5.2 Biosimilar Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL BIOSIMILAR SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Biosimilar Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Biosimilar Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Biosimilar Market Under COVID-19
4.5 Europe Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Biosimilar Market Under COVID-19
4.6 China Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Biosimilar Market Under COVID-19
4.7 Japan Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Biosimilar Market Under COVID-19
4.8 India Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Biosimilar Market Under COVID-19
4.9 Southeast Asia Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Biosimilar Market Under COVID-19
4.10 Latin America Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Biosimilar Market Under COVID-19
4.11 Middle East and Africa Biosimilar Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Biosimilar Market Under COVID-19

5 GLOBAL BIOSIMILAR SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Biosimilar Sales Volume and Market Share by Type (2017-2022)
5.2 Global Biosimilar Revenue and Market Share by Type (2017-2022)
5.3 Global Biosimilar Price by Type (2017-2022)
5.4 Global Biosimilar Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Biosimilar Sales Volume, Revenue and Growth Rate of Human Growth Hormones (2017-2022)
  5.4.2 Global Biosimilar Sales Volume, Revenue and Growth Rate of Monoclonal Antibodies (2017-2022)
  5.4.3 Global Biosimilar Sales Volume, Revenue and Growth Rate of Insulin (2017-2022)
  5.4.4 Global Biosimilar Sales Volume, Revenue and Growth Rate of Peptides (2017-2022)
  5.4.5 Global Biosimilar Sales Volume, Revenue and Growth Rate of Erythropoietin (2017-2022)

6 GLOBAL BIOSIMILAR MARKET ANALYSIS BY APPLICATION

6.1 Global Biosimilar Consumption and Market Share by Application (2017-2022)
6.2 Global Biosimilar Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Biosimilar Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Biosimilar Consumption and Growth Rate of Oncology (2017-2022)
  6.3.2 Global Biosimilar Consumption and Growth Rate of Chronic and Autoimmune Diseases (2017-2022)
  6.3.3 Global Biosimilar Consumption and Growth Rate of Growth Hormone Deficiency (2017-2022)
  6.3.4 Global Biosimilar Consumption and Growth Rate of Infectious Diseases (2017-2022)
  6.3.5 Global Biosimilar Consumption and Growth Rate of Others (2017-2022)

7 GLOBAL BIOSIMILAR MARKET FORECAST (2022-2027)

7.1 Global Biosimilar Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Biosimilar Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Biosimilar Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Biosimilar Price and Trend Forecast (2022-2027)
7.2 Global Biosimilar Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Biosimilar Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Biosimilar Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Biosimilar Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Biosimilar Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Biosimilar Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Biosimilar Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Biosimilar Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Biosimilar Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Biosimilar Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Biosimilar Revenue and Growth Rate of Human Growth Hormones (2022-2027)
  7.3.2 Global Biosimilar Revenue and Growth Rate of Monoclonal Antibodies (2022-2027)
  7.3.3 Global Biosimilar Revenue and Growth Rate of Insulin (2022-2027)
  7.3.4 Global Biosimilar Revenue and Growth Rate of Peptides (2022-2027)
  7.3.5 Global Biosimilar Revenue and Growth Rate of Erythropoietin (2022-2027)
7.4 Global Biosimilar Consumption Forecast by Application (2022-2027)
  7.4.1 Global Biosimilar Consumption Value and Growth Rate of Oncology(2022-2027)
  7.4.2 Global Biosimilar Consumption Value and Growth Rate of Chronic and Autoimmune Diseases(2022-2027)
  7.4.3 Global Biosimilar Consumption Value and Growth Rate of Growth Hormone Deficiency(2022-2027)
  7.4.4 Global Biosimilar Consumption Value and Growth Rate of Infectious Diseases(2022-2027)
  7.4.5 Global Biosimilar Consumption Value and Growth Rate of Others(2022-2027)
7.5 Biosimilar Market Forecast Under COVID-19

8 BIOSIMILAR MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Biosimilar Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Biosimilar Analysis
8.6 Major Downstream Buyers of Biosimilar Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Biosimilar Industry

9 PLAYERS PROFILES

9.1 Novartis
  9.1.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Biosimilar Product Profiles, Application and Specification
  9.1.3 Novartis Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Pfizer
  9.2.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Biosimilar Product Profiles, Application and Specification
  9.2.3 Pfizer Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Celltrion
  9.3.1 Celltrion Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Biosimilar Product Profiles, Application and Specification
  9.3.3 Celltrion Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 BioXpress Therapeutics
  9.4.1 BioXpress Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Biosimilar Product Profiles, Application and Specification
  9.4.3 BioXpress Therapeutics Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Boehringer Ingelheim
  9.5.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Biosimilar Product Profiles, Application and Specification
  9.5.3 Boehringer Ingelheim Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Genor BioPharma
  9.6.1 Genor BioPharma Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Biosimilar Product Profiles, Application and Specification
  9.6.3 Genor BioPharma Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Allergan plc
  9.7.1 Allergan plc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Biosimilar Product Profiles, Application and Specification
  9.7.3 Allergan plc Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Intas Pharmaceuticals Limited
  9.8.1 Intas Pharmaceuticals Limited Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Biosimilar Product Profiles, Application and Specification
  9.8.3 Intas Pharmaceuticals Limited Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Reliance Life Sciences
  9.9.1 Reliance Life Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Biosimilar Product Profiles, Application and Specification
  9.9.3 Reliance Life Sciences Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 BIOCAD
  9.10.1 BIOCAD Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Biosimilar Product Profiles, Application and Specification
  9.10.3 BIOCAD Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 Dr. Reddy’s Laboratories
  9.11.1 Dr. Reddy’s Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Biosimilar Product Profiles, Application and Specification
  9.11.3 Dr. Reddy’s Laboratories Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis
9.12 Coherus BioSciences
  9.12.1 Coherus BioSciences Basic Information, Manufacturing Base, Sales Region and Competitors
  9.12.2 Biosimilar Product Profiles, Application and Specification
  9.12.3 Coherus BioSciences Market Performance (2017-2022)
  9.12.4 Recent Development
  9.12.5 SWOT Analysis
9.13 Biocon
  9.13.1 Biocon Basic Information, Manufacturing Base, Sales Region and Competitors
  9.13.2 Biosimilar Product Profiles, Application and Specification
  9.13.3 Biocon Market Performance (2017-2022)
  9.13.4 Recent Development
  9.13.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES

Figure Biosimilar Product Picture
Table Global Biosimilar Market Sales Volume and CAGR (%) Comparison by Type
Table Biosimilar Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Biosimilar Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Biosimilar Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Biosimilar Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Biosimilar Industry Development
Table Global Biosimilar Sales Volume by Player (2017-2022)
Table Global Biosimilar Sales Volume Share by Player (2017-2022)
Figure Global Biosimilar Sales Volume Share by Player in 2021
Table Biosimilar Revenue (Million USD) by Player (2017-2022)
Table Biosimilar Revenue Market Share by Player (2017-2022)
Table Biosimilar Price by Player (2017-2022)
Table Biosimilar Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Biosimilar Sales Volume, Region Wise (2017-2022)
Table Global Biosimilar Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Biosimilar Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Biosimilar Sales Volume Market Share, Region Wise in 2021
Table Global Biosimilar Revenue (Million USD), Region Wise (2017-2022)
Table Global Biosimilar Revenue Market Share, Region Wise (2017-2022)
Figure Global Biosimilar Revenue Market Share, Region Wise (2017-2022)
Figure Global Biosimilar Revenue Market Share, Region Wise in 2021
Table Global Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Biosimilar Sales Volume by Type (2017-2022)
Table Global Biosimilar Sales Volume Market Share by Type (2017-2022)
Figure Global Biosimilar Sales Volume Market Share by Type in 2021
Table Global Biosimilar Revenue (Million USD) by Type (2017-2022)
Table Global Biosimilar Revenue Market Share by Type (2017-2022)
Figure Global Biosimilar Revenue Market Share by Type in 2021
Table Biosimilar Price by Type (2017-2022)
Figure Global Biosimilar Sales Volume and Growth Rate of Human Growth Hormones (2017-2022)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Human Growth Hormones (2017-2022)
Figure Global Biosimilar Sales Volume and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Biosimilar Sales Volume and Growth Rate of Insulin (2017-2022)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Insulin (2017-2022)
Figure Global Biosimilar Sales Volume and Growth Rate of Peptides (2017-2022)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Peptides (2017-2022)
Figure Global Biosimilar Sales Volume and Growth Rate of Erythropoietin (2017-2022)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Erythropoietin (2017-2022)
Table Global Biosimilar Consumption by Application (2017-2022)
Table Global Biosimilar Consumption Market Share by Application (2017-2022)
Table Global Biosimilar Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Biosimilar Consumption Revenue Market Share by Application (2017-2022)
Table Global Biosimilar Consumption and Growth Rate of Oncology (2017-2022)
Table Global Biosimilar Consumption and Growth Rate of Chronic and Autoimmune Diseases (2017-2022)
Table Global Biosimilar Consumption and Growth Rate of Growth Hormone Deficiency (2017-2022)
Table Global Biosimilar Consumption and Growth Rate of Infectious Diseases (2017-2022)
Table Global Biosimilar Consumption and Growth Rate of Others (2017-2022)
Figure Global Biosimilar Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Biosimilar Price and Trend Forecast (2022-2027)
Figure USA Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Biosimilar Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Biosimilar Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Biosimilar Market Sales Volume Forecast, by Type
Table Global Biosimilar Sales Volume Market Share Forecast, by Type
Table Global Biosimilar Market Revenue (Million USD) Forecast, by Type
Table Global Biosimilar Revenue Market Share Forecast, by Type
Table Global Biosimilar Price Forecast, by Type
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Human Growth Hormones (2022-2027)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Human Growth Hormones (2022-2027)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Insulin (2022-2027)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Insulin (2022-2027)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Peptides (2022-2027)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Peptides (2022-2027)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Erythropoietin (2022-2027)
Figure Global Biosimilar Revenue (Million USD) and Growth Rate of Erythropoietin (2022-2027)
Table Global Biosimilar Market Consumption Forecast, by Application
Table Global Biosimilar Consumption Market Share Forecast, by Application
Table Global Biosimilar Market Revenue (Million USD) Forecast, by Application
Table Global Biosimilar Revenue Market Share Forecast, by Application
Figure Global Biosimilar Consumption Value (Million USD) and Growth Rate of Oncology (2022-2027)
Figure Global Biosimilar Consumption Value (Million USD) and Growth Rate of Chronic and Autoimmune Diseases (2022-2027)
Figure Global Biosimilar Consumption Value (Million USD) and Growth Rate of Growth Hormone Deficiency (2022-2027)
Figure Global Biosimilar Consumption Value (Million USD) and Growth Rate of Infectious Diseases (2022-2027)
Figure Global Biosimilar Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Biosimilar Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Novartis Profile
Table Novartis Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Biosimilar Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Biosimilar Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Celltrion Profile
Table Celltrion Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celltrion Biosimilar Sales Volume and Growth Rate
Figure Celltrion Revenue (Million USD) Market Share 2017-2022
Table BioXpress Therapeutics Profile
Table BioXpress Therapeutics Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BioXpress Therapeutics Biosimilar Sales Volume and Growth Rate
Figure BioXpress Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Biosimilar Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Genor BioPharma Profile
Table Genor BioPharma Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genor BioPharma Biosimilar Sales Volume and Growth Rate
Figure Genor BioPharma Revenue (Million USD) Market Share 2017-2022
Table Allergan plc Profile
Table Allergan plc Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Allergan plc Biosimilar Sales Volume and Growth Rate
Figure Allergan plc Revenue (Million USD) Market Share 2017-2022
Table Intas Pharmaceuticals Limited Profile
Table Intas Pharmaceuticals Limited Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Intas Pharmaceuticals Limited Biosimilar Sales Volume and Growth Rate
Figure Intas Pharmaceuticals Limited Revenue (Million USD) Market Share 2017-2022
Table Reliance Life Sciences Profile
Table Reliance Life Sciences Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Reliance Life Sciences Biosimilar Sales Volume and Growth Rate
Figure Reliance Life Sciences Revenue (Million USD) Market Share 2017-2022
Table BIOCAD Profile
Table BIOCAD Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BIOCAD Biosimilar Sales Volume and Growth Rate
Figure BIOCAD Revenue (Million USD) Market Share 2017-2022
Table Dr. Reddy’s Laboratories Profile
Table Dr. Reddy’s Laboratories Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dr. Reddy’s Laboratories Biosimilar Sales Volume and Growth Rate
Figure Dr. Reddy’s Laboratories Revenue (Million USD) Market Share 2017-2022
Table Coherus BioSciences Profile
Table Coherus BioSciences Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Coherus BioSciences Biosimilar Sales Volume and Growth Rate
Figure Coherus BioSciences Revenue (Million USD) Market Share 2017-2022
Table Biocon Profile
Table Biocon Biosimilar Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biocon Biosimilar Sales Volume and Growth Rate
Figure Biocon Revenue (Million USD) Market Share 2017-2022


More Publications